Fritextsökning
Innehållstyper
-
Överges av Pfizer
Nu letar Saniona efter ny partner och planerar en klinisk studie på typ 2-diabetes.
-
Discovery of new role for leukemia gene
Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell d...
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
USA vill öka transparensen
Vill ändra lagstiftningen för öka mängden tillgänglig information från kliniska studier.
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Satsar på två marknader
Göteborgsbaserade Albireos förhoppning med nya dotterbolaget i Boston är att kunna dra nytta av båda marknader i sin utveckling till ett globalt läkemedelsbolag.
-
Ny dryck mot blodsockersvängning
Vatten med krom och aminosyror kan dämpa blodsockerstegringen som uppstår när man äter.
-
Travelling scholarship to DTU professor
The Vera og Carl Johan Michaelsens Rejselegat has the founder of the Medicine and Technology program at DTU with a scholarship.
-
Raysearch tappar chef
Finanschefen lämnar medtechbolaget i april.
-
SDU professor helps EU
Mette Præst Knudsen from the University of Southern Denmark, SDU, has been appointed as an expert member in an EU politics group.
-
Polymer guru new dean at DTU
The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.
-
Kombinationsstudie med simeprevir visar positiva resultat
Medivirs hepatit C-läkemedel simeprevir har genomgått en lyckad fas IIa-studie ihop med BMS dito. Men fler studier krävs för att ge en helhetsbedömning.
-
Proteinkartan uppdateras
Den nya versionen av Human Protein Atlas innehåller en uppdaterad karta över proteindistributionen i mushjärnan och en validering av de antikroppar som använts i projektet.
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
New nano professor in Denmark
The Technical University of Denmark has appointed a recognized physicist as a new professor of miniaturized sensors.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Han leder nya Göteborgscentret
Professor Göran Landberg har utsetts till föreståndare för det nya Wallenbergcentret för molekylär och translationell medicin.
-
Platelet analysis in whole blood
The new Multiplate analyzer from Triolab uses impedance aggregometry to measure the effects of platelet inhibitors on whole blood.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Control of blood vessels can treat obesity
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet.
BREAKING